| Literature DB >> 30950980 |
Ana-Catarina Pinho-Gomes1,2, Luis Azevedo3, Zeinab Bidel4, Milad Nazarzadeh1,2, Dexter Canoy1,2,5, Emma Copland2,5, Abdul Salam6, Anthony Rodgers7, Dipak Kotecha8,9, Kazem Rahimi1,2,5.
Abstract
: We aimed to combine evidence from all heart failure trials that have investigated the effects of drugs with blood pressure (BP)-lowering properties to assess the extent to which such drugs reduce BP in heart failure, the association between the net change in BP between treatment arms and cause-specific outcomes and whether treatment effects (efficacy and safety) vary according to baseline BP. We conducted a systematic review and meta-analysis including randomized clinical trials of drugs with BP-lowering properties in patients with chronic heart failure with at least 300 patient-years follow-up. We included a total of 37 trials (91 950 patients) and showed that treatment with drugs with BP-lowering properties resulted in a small but significant decrease in SBP in patients with heart failure with no evidence that the efficacy and safety of those drugs varied according to baseline BP.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30950980 DOI: 10.1097/HJH.0000000000002094
Source DB: PubMed Journal: J Hypertens ISSN: 0263-6352 Impact factor: 4.844